Form 4 for MRK Merck & Co.
Accepted 2025-05-02 00:00:00 ET · period of report 2025-04-30 · accession 0001127602-25-013182 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-02 | 2025-04-30+ | MRK | Romanelli Joseph | Pres, Human Health Int?l | M - OptEx | $83.95 | +4,325 | 24.1K | +22% | +$363.1K |
| DM | 2025-05-02 | 2025-04-30+ | MRK | Romanelli Joseph | Pres, Human Health Int?l | F - Tax | $83.95 | -2,132 | 22.9K | -9% | -$179.0K |
| DM | 2025-05-02 | 2025-04-30+ | MRK | Romanelli Joseph | Pres, Human Health Int?l | M - OptEx | $0.00 | -4,325 | 2,262 | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-30 | M | A | 2,063 | $84.71 | 22,815.55 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-30 | F | D | 1,017 | $84.71 | 21,798.55 | D | — | — | |
| 3 | Common | Common Stock | 2025-05-02 | M | A | 2,262 | $83.26 | 24,060.55 | D | — | — | |
| 4 | Common | Common Stock | 2025-05-02 | F | D | 1,115 | $83.26 | 22,945.55 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 5 | Derivative | Restricted Stock Unit | 2025-04-30 | M | D | 2,063 | $0.00 | 4,128 | D | — · 2025-04-30 to 2027-04-30 | 2,063 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. |
| 6 | Derivative | Restricted Stock Unit | 2025-05-02 | M | D | 2,262 | $0.00 | 2,262 | D | — · 2024-05-02 to 2026-05-02 | 2,262 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F4) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026. |